ArticleBJC reports2023

Metformin may improve the outcome of patients with colorectal cancer and type 2 diabetes mellitus partly through effects on neutrophil extracellular traps.

Akira Saito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.